Northwire Canada EditionThursday, October 15, 2026
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Earnings Routine +

Victory Square Technologies Reports Fiscal 2025 Results Highlighting Platform Scaling, Healthcare Infrastructure Growth and Portfolio Momentum

Hydreight Revenue Guidance Confirmed, But Execution Risk Remains on 4x Growth Target

Executive Summary
  • Victory Square Technologies reported Fiscal 2025 audited financial results showing consolidated revenue of $35.4 million, a 121% increase year-over-year from FY2024 ($16.04M).
  • Hydreight Technologies Inc., the primary operating subsidiary, contributed significantly to this growth with adjusted EBITDA turning positive at $2.5 million compared to $136K in FY2024.
  • The company reiterated forward revenue guidance for Fiscal 2026 of approximately $150 million for Hydreight Technologies, a figure previously disclosed in February 2026.
  • Cash and marketable securities increased to $22.0 million with working capital at $15.0 million, indicating improved liquidity compared to prior periods.
  • Operational metrics show over 11,000 licenses signed for the VSDHOne healthcare platform and a distribution of Yocale.ai shares completed in April 2026.
  • Pawsible Ventures launched a $10M venture fund targeting pet health infrastructure, expanding the company's portfolio beyond digital health.
Material Impact
  • The Fiscal 2025 revenue beat ($35.4M vs FY2024 $16.04M) validates the growth trajectory but does not introduce new upside beyond expectations set in February 2026 when the $150M guidance was first issued.
  • Profitability improvement (Adjusted EBITDA of $2.5M) is a positive confirmation that Hydreight has reached operational leverage, reducing the risk of immediate capital dilution for operations.
  • The reiterated $150M FY2026 guidance represents a 4x increase from current run rates; while confirmed by management, this remains an aggressive target with significant execution risk if partner activity does not scale as projected.
  • Since the core catalyst (the $150M guidance) was already public in February and March news releases, this earnings release is largely confirmatory rather than transformative for valuation.
  • The stock price has corrected from September highs ($0.98) to current levels ($0.72), suggesting the market may have priced in the growth expectations earlier; this news reinforces the thesis but does not justify a new breakout without further catalysts.
VST · Price
Company Overview
  • Company: Victory Square Technologies Inc. (CSE: VST).
  • Flagship Project: Hydreight Technologies Inc., a digital health infrastructure platform operating across 50 U.S. states.
  • Platform: VSDHOne, a modular compliance framework for telehealth and pharmacy fulfillment supporting GLP-1s, TRT, peptides, and other categories.
  • Portfolio: Includes Insu Therapeutics (biotech), Pawsible Ventures (pet health fund), SafeTest Diagnósticos (Brazil diagnostics), and XR Immersive Technologies.
  • Business Model: Revenue generated through platform licensing, transaction fees on product orders placed, and venture investments in portfolio companies.
Read the original news release →

More from Victory Square Technologies Inc.